Stanley C Erck's Net Worth
$40.8 Million
Who is Stanley C Erck?
Stanley C Erck has an estimated net worth of $40.8 Million. This is based on reported shares across multiple companies, which include INTERCELL USA, INC., NOVAVAX INC, MAXCYTE, INC., and BIOCRYST PHARMACEUTICALS INC.
SEC CIK
Stanley C Erck's CIK is 0001342826
Past Insider Trading and Trends
2021 was Stanley C Erck's most active year for acquiring shares with 12 total transactions. Stanley C Erck's most active month to acquire stocks was the month of February. 2021 was Stanley C Erck's most active year for disposing of shares, totalling 66 transactions. Stanley C Erck's most active month to dispose stocks was the month of September. 2021 saw Stanley C Erck paying a total of $9,987,459.00 for 220,521 shares, this is the most they've acquired in one year. In 2021 Stanley C Erck cashed out on 414,057 shares for a total of $40,024,454.82, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTERCELL USA, INC. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -25.00K |
$6.60 | -$165,006.60 |
0
|
Aug 5
| |||
Form 4
| +0.00% | 1 |
$5.92 | -$176,015.50 | 25K |
Jul 29 - Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 4
|
∞
| 25K |
$0.91 | $22,750.00 | 25K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVAVAX INC (NVAX) Snapshot price: $3.78
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.59% | 4.65K |
$17.23 | -$39,973.60 | 36.49K |
Dec 14
| |||
Form 4
| +15.89% | 4.37K |
$18.87 | -$41,136.60 | 31.85K |
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +15.08% | 3.6K |
$168.43 | -$566,935.38 | 27.48K |
Dec 14
| |||
Form 4
|
—
|
0
|
$101.80 | -$6,368,611.71 | 23.88K |
Scheduled
|
Oct 4
| ||
Form 4
|
—
|
0
|
$101.14 | -$7,248,663.84 | 23.88K |
Scheduled
|
Oct 1
| ||
Form 4
| +16.51% | 3.38K |
$248.16 | -$784,681.92 | 23.88K |
Sep 26
| |||
Form 4
|
—
|
0
|
$142.75 | -$15,068,103.01 | 20.5K |
Scheduled
|
Jul 1 - Jul 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
| +0.00% | 1 |
$63.90 | -$2,799,865.96 | 20.5K |
Scheduled
|
Nov 16
| ||
Form 4
| -37.38% | -12.23K |
$110.23 | -$1,348,417.52 | 20.49K |
Scheduled
|
Sep 30 - Oct 1
| ||
Form 4
| +33.00% | 8.12K |
$58.14 | -$4,322,657.21 | 32.73K |
Scheduled
|
Sep 28 - Sep 29
| ||
Form 4
| +20.06% | 4.11K |
$113.56 | -$276,405.04 | 24.61K |
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26 - Jun 25
| |||
Form 4
| +24.86% | 4.08K |
$12.48 | -$24,860.16 | 20.49K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
| +43.81% | 100K |
$1.65 | $164,620.00 | 328.28K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| +77.96% | 100K |
$1.13 | $113,050.00 | 228.28K |
Nov 9
| |||
Form 4
| +63.87% | 50K |
$0.84 | $41,980.00 | 128.28K |
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
| -24.04% | -24.78K |
$3.24 | -$1,691,619.18 | 78.28K |
Mar 30 - Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +2.05% | 2.07K |
$4.38 | $9,075.36 | 103.06K |
Jan 31
| |||
Form 4
| +3.28% | 3.21K |
$2.28 | $7,311.96 | 100.98K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
| +6.68% | 6.12K |
$2.28 | $13,958.16 | 97.78K |
Jan 31
| |||
Form 4
| +8.00% | 6.79K |
$2.28 | $15,476.64 | 91.66K |
Jul 31
| |||
Form 4/A
| +13.36% | 10K |
$4.27 | $42,698.00 | 84.87K |
Mar 25
| |||
Form 4
| -10.54% | -10.00K |
$4.27 | -$42,698.00 | 84.87K |
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
| +18.84% | 11.87K |
$2.29 | $27,177.72 | 74.87K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 13K |
$1.26 | $16,380.00 | 13K |
Aug 19
| |||
Form 4
|
∞
| 50K |
$1.24 | $62,000.00 | 50K |
Aug 9 - Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MAXCYTE, INC. (MXCT) Snapshot price: $4.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.62% | 21.37K |
—
|
—
| 269.12K |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOCRYST PHARMACEUTICALS INC (BCRX) Snapshot price: $5.315
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.83% | 8.33K |
$1.49 | $12,416.17 | 48.33K |
Nov 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
∞
| 40K |
$1.22 | $48,880.00 | 40K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||